Antibodies to nodal/paranodal proteins in paediatric immune-mediated neuropathy

Desiree De Simoni, Gerda Ricken, Michael Winklehner, Inga Koneczny, Michael Karenfort, Ulf Hustedt, Ulrich Seidel, Omar Abdel-Mannan, Pinki Munot, Simon Rinaldi, Claudia Steen, Michael Freilinger, Markus Breu, Rainer Seidl, Markus Reindl, Julia Wanschitz, Cinta Lleixà, Günther Bernert, Klaus-Peter Wandinger, Ralf JunkerLuis Querol, Frank Leypoldt, Kevin Rostásy, Romana Höftberger

Research output: Journal article (peer-reviewed)Journal article

14 Citations (Scopus)


Patients with nodal/paranodal antibodies represent a specific subgroup of inflammatory peripheral neuropathies, whose clinical presentation with a prolonged subacute phase, additional symptoms such as ataxia and tremor, and poor treatment response to IV immunoglobulin (IVIG) often differs from classic Guillain-Barré syndrome (GBS) or chronic inflammatory demyelinating polyneuropathy (CIDP).1.

Original languageEnglish
Article numbere763
JournalNeurology: Neuroimmunology and NeuroInflammation
Issue number4
Publication statusPublished - 01 Jul 2020


  • Adolescent
  • Autoantibodies
  • Cell Adhesion Molecules, Neuronal/immunology
  • Child
  • Child, Preschool
  • Female
  • Guillain-Barre Syndrome/immunology
  • Humans
  • Infant
  • Male
  • Nerve Growth Factors/immunology
  • Nodal Protein/immunology
  • Polyradiculoneuropathy, Chronic Inflammatory Demyelinating/immunology
  • Retrospective Studies


Dive into the research topics of 'Antibodies to nodal/paranodal proteins in paediatric immune-mediated neuropathy'. Together they form a unique fingerprint.

Cite this